CSPC Pharmaceutical Invites New Shareholders to Opt for Electronic Corporate Communications; Default Choice Effective 17 Oct 2026

Bulletin Express
09/17

CSPC Pharmaceutical Group Limited has issued a notice to newly registered shareholders outlining the procedure for choosing how future corporate communications will be received. Under Hong Kong Stock Exchange listing requirements and the company’s articles of association, shareholders may receive materials either in printed form or electronically via the company’s website (www.cspc.com.hk) and the HKEx website (www.hkexnews.hk).

Key details of the notice are as follows:

• Election Process: Shareholders are requested to complete and return a reply form—by post or in person—to the company’s share registrar, Tricor Investor Services Limited. The registrar’s address is 17/F, Far East Finance Centre, 16 Harcourt Road, Hong Kong. Domestic mail can be sent postage-free using the provided mailing label.

• Default to Electronic Delivery: If a completed reply form or other response is not received by 17 October 2026, the shareholder will be deemed to have chosen the electronic version. A notification of each posting will then be sent by email or, if no email address is provided, by post.

• Switching Options: Shareholders may change their chosen communication method at any time by sending written notice to the registrar at the above address or via email to cspc1093-ecom@vistra.com. Printed copies will be supplied free of charge upon request if electronic access proves difficult.

• Availability of Documents: Both English and Chinese versions of corporate communications—including annual and interim reports, notices of meetings, circulars and proxy forms—will remain accessible on the company and HKEx websites. Printed versions can be obtained from the company or the registrar on request.

• Contact Information: Queries can be directed to the company’s hotline at +852 2980 1333 during business hours (9:00 a.m.–5:00 p.m., Monday to Friday, excluding Hong Kong public holidays).

The announcement underscores CSPC Pharmaceutical’s efforts to enhance communication efficiency and support environmental sustainability through wider adoption of electronic documentation.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10